Home › NDC Lookup › Ingredients › Clonidine Hydrochloride › 46708-0308-10
⚪image loading
(from DailyMed)

clonidine hydrochloride .3 mg Tablet, 100-count — NDC 46708-308-10 (Billing 46708-0308-10)

by Alembic Pharmaceuticals Limited · 100 TABLET in 1 CARTON

This is a package of 100 tablets of clonidine hydrochloride .3 mg Tablet from Alembic Pharmaceuticals Limited, marketed since May 2016 and currently FDA-listed. It is the main listing for this product, which comes in 5 package sizes.

NDC 46708-0308-10
🏷️ FDA NDC (as labeled) 46708-308-10 billing pads the product segment with a zero
This package
Contains100-count Pack sizes5 compare ↓
Also priced by: Part D plans $0.0688/unit — full pricing hub ↓
Rx only Generic On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Oct 8, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

NDC database record

One package, one record: these facts belong to NDC 46708-308-10 alone.

Record
FDA NDC Directory package listing · Human prescription drug
Code segments
46708 labeler · 308 product · 10 package
Package marketed since
May 3, 2016
Sample package
No — commercial package
Listing certified through
Dec 31, 2026
Barcode (UPC-A, from the NDC)
3 4670830810 0
FDA record last changed
Oct 8, 2026

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 46708-308-10
Product NDC 46708-308
11-digit billing NDC 46708030810
Application # ANDA091368
SPL Set ID 5c1950f4-ba20-4347-8ca0-f50a2d66c039
Established class (EPC) Central alpha-2 Adrenergic Agonist
Mechanism of action Adrenergic alpha2-Agonists
DEA schedule Non-controlled
Marketing category ANDA
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2016-05-03
Route ORAL
Dosage form TABLET
Substance CLONIDINE HYDROCHLORIDE
TE code (Orange Book) AB · RLD · RS
Why two NDCs? The FDA registers this code as 46708-308-10 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 46708-0308-10. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

Clinical

📖 What it is MedlinePlus · NLM

Clonidine is used alone or in combination with other medications to treat high blood pressure. Clonidine is also used alone or in combination with other medications as part of a treatment program to control symptoms of attention deficit hyperactivity disorder (ADHD; more difficulty focusing, controlling actions, and remaining still or quiet than other people who are the same age) in children 6 years of age and older. Clonidine is in a class of medications called centrally acting alpha-agonist hypotensive agents. Clonidine treats high blood pressure by decreasing your heart rate and relaxing th...

Read the full MedlinePlus article ↗
📗 Our plain-language guide HelloPharmacist
  • It depends on the product. Tablets, oral solutions, Nexiclon XR and patches lower high blood pressure. Certain extended-release products treat ADHD. The epidural injection is used...
  • No. Stopping suddenly can cause rebound high blood pressure, with headache, a racing heart, nervousness and anxiety. Your doctor will lower the dose gradually.
  • Sleepiness is common. Don't drive or use heavy equipment until you know how it affects you. Avoid alcohol, and ask me before combining it with other sedating medicines.
  • No. Extended-release clonidine tablets should be swallowed whole, not crushed, chewed or broken. They can be taken with or without food.
📖 Read our full Clonidine guide →
1
Nutrient depletion considerations

Clonidine may be associated with lower levels of 1 nutrient — worth a chat with your pharmacist, not a cause for alarm.

An association is not a deficiency. Educational only — don't start or stop anything without professional guidance.
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eachPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · Q2 2026 $0.0688 $6.88 / 100 tablets
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
46708-0308-10 You're viewing this Main listing 100 TABLET in 1 CARTON 2016-05-03 — Active
46708-0308-30 46708-308-30 30 TABLET in 1 BOTTLE 2016-05-03 — Active
46708-0308-31 46708-308-31 100 TABLET in 1 BOTTLE 2016-05-03 — Active
46708-0308-71 46708-308-71 500 TABLET in 1 BOTTLE 2016-05-03 — Active
46708-0308-91 46708-308-91 1000 TABLET in 1 BOTTLE 2016-05-03 — Active

Pack size FAQ

What quantity is in this package?
This is a 100-count package — 100 tablet in 1 carton.
How does this package differ from NDC 46708-0308-30?
Both are clonidine hydrochloride .3 mg Tablet — the drug itself is identical. This page's package is the 100-count one, while NDC 46708-0308-30 is the 30 tablets package.
What NDC number is used to bill for this package of clonidine hydrochloride .3 mg Tablet?
Use the 11-digit billing form listed in the identifiers section of this page. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Clonidine Hydrochloride .3 mg 00228-2129-10 Actavis 100 tablets $0.041 AB Availability likely —
clonidine hydrochloride .3 mg 29300-0137-01 Unichem 100 tablets $0.041 AB Availability likely —
Clonidine Hydrochloride .3 mg 43547-0567-10 Solco 100 tablets $0.041 AB Availability likely —
clonidine hydrochloride .3 mg 50268-0194-15 AvPAK 50 tablets $0.041 AB Availability likely —
Clonidine hydrochloride .3 mg 52817-0182-00 TruPharma, 1000 tablets $0.041 — Availability likely —
Clonidine Hydrochloride .3 mg 58657-0649-01 Method 100 tablets $0.041 AB Availability likely —
Clonidine Hydrochloride .3 mg 59651-0234-01 Aurobindo 100 tablets $0.041 AB Availability likely —
Clonidine Hydrochloride .3 mg 68001-0239-00 BluePoint 100 tablets $0.041 AB Availability likely —
clonidine hydrochloride .3 mg 43063-0924-30 PD-Rx 30 tablets — AB FDA listed —
Clonidine Hydrochloride .3 mg 43353-0316-09 Aphena 9000 tablets — AB FDA listed —
clonidine hydrochloride .3 mgthis 46708-0308-10 Alembic 100 tablets — AB FDA listed —
clonidine hydrochloride .3 mg 50090-1910-00 A-S 100 tablets — AB FDA listed —
clonidine hydrochloride .3 mg 51655-0339-25 Northwind 60 tablets — AB FDA listed —
Clonidine hydrochloride .3 mg 51655-0451-25 Northwind 60 tablets — — FDA listed —
clonidine hydrochloride .3 mg 62332-0056-10 Alembic 100 tablets — AB FDA listed —
Clonidine Hydrochloride .3 mg 63629-2318-01 Bryant 500 tablets — AB FDA listed —
Clonidine Hydrochloride .3 mg 63629-2319-01 Bryant 100 tablets — AB FDA listed —
clonidine hydrochloride .3 mg 66267-0464-90 NuCare 90 tablets — AB FDA listed —
clonidine hydrochloride .3 mg 68788-8163-01 Preferred 100 tablets — AB FDA listed —
clonidine hydrochloride .3 mg 70518-2203-01 REMEDYREPACK 30 tablets — AB FDA listed —
Clonidine Hydrochloride .3 mg 70518-4379-00 REMEDYREPACK 60 tablets — AB FDA listed —
clonidine hydrochloride .3 mg 71335-0915-01 Bryant 60 tablets — AB Discontinued —
Clonidine hydrochloride .3 mg 71335-1624-01 Bryant 60 tablets — — Discontinued —
Clonidine Hydrochloride .3 mg 71335-2889-01 Bryant 500 tablets — AB FDA listed —
Clonidine Hydrochloride .3 mg 71335-9682-01 Bryant 60 tablets — AB FDA listed —
Clonidine hydrochloride .3 mg 71610-0449-09 Aphena 9000 tablets — — FDA listed —
Clonidine Hydrochloride .3 mg 72162-1681-01 Bryant 100 tablets — AB FDA listed —
Clonidine Hydrochloride .3 mg 72162-2611-05 Bryant 500 tablets — AB FDA listed —
Clonidine hydrochloride .3 mg 76420-0286-01 Asclemed 100 tablets — — FDA listed —
clonidine hydrochloride .3 mg 87063-0183-01 ASCLEMED 100 tablets — AB FDA listed —
Clonidine Hydrochloride .3 mg 00615-2574-39 NCS 30 tablets — AB Discontinued —
clonidine hydrochloride .3 mg 67046-0646-03 Coupler 30 tablets — AB FDA listed —
About this product: this is a generic version of the medicine. FDA equivalence ratings are shown when available, and other versions are listed above, least expensive first.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2016
On the market since
May 2016
📍
2026
Currently FDA-listed
10 years listed
🔓
·
Generic on the market
this product is a generic
✅This is a generic drug

This product is an FDA-approved generic. Other versions of the same drug are listed under Therapeutic equivalents, least expensive first.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

🧪 Avoiding an ingredient? See Clonidine inactive ingredients by manufacturer: every current product's list side by side, so you can ask your pharmacy for the version that does not list it.

Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerAlembic Pharmaceuticals Limited
Application holderALEMBIC PHARMACEUTICALS LTD
FDA applicationANDA091368 (ANDA)
Labeler code46708
First marketedMay 2016
Product typeHuman Prescription Drug
Portfolio502 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

Full prescribing information FDA SPL

The complete FDA label for this product — the official prescribing information, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
📄 FDA label 19 words ▾

No FDA label is on file for this product yet. Labels load from openFDA / DailyMed and refresh weekly.

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

About this NDC listing & data coverage

Finished prescription product
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos — Not published for this NDC No photo available yet for this listing.
Inactive ingredients (structured) — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available.
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data ✓ Available
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Alembic Pharmaceuticals Limited. Listing status can change — the directory data on this page refreshes weekly.
Does this product come in other package sizes?
Yes — the FDA directory lists 4 other package presentations of this same product, including 30 tablets (46708-0308-30), 100 tablets (46708-0308-31), 500 tablets (46708-0308-71). Each has its own NDC and its own page — see the package list near the top of this page.
Who lists this product with the FDA?
Alembic Pharmaceuticals Limited is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as a prescription product, so it is dispensed under a prescriber's order. Your pharmacist can tell you whether any over-the-counter forms of the same medication exist.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.